Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Maida

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|July 29, 2023
Multiple Sclerosis: Diagnosis, Management, and Future OpportunitiesElisabetta Maida, Luigi Lavorgna
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 1, 2026
Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessmentFrancesco Brigo, Arian Zaboli, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2026
AI for clinical neurology: Comparing five large language models in neurological diagnosis and lesion localizationFrancesco Brigo, Arian Zaboli, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2023
Viral pericarditis following ocrelizumab in a multiple sclerosis patientGiuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, et al.
Journal of Neurology|August 16, 2025
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosisGianmarco Abbadessa, Elisabetta Maida, Simona Bonavita, et al.
Journal of Clinical Medicine|October 27, 2022
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case SeriesGianmarco Abbadessa, Elisabetta Maida, Giuseppina Miele, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic reviewGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 19, 2023
Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic ReviewElisabetta Maida, Vincenzo Bresciamorra, Maria Triassi, et al.
Journal of Clinical Medicine|April 13, 2024
A Review on the Feasibility and Efficacy of Home-Based Cognitive Remediation in People with Multiple SclerosisAngela Boschetti, Elisabetta Maida, Michelangelo Dini, et al.
Multiple Sclerosis and Related Disorders|November 25, 2023
Validation of the swallowing disturbance questionnaire in people with multiple sclerosisMaddalena Sparaco, Elisabetta Maida, Floriana Bile, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|July 29, 2023
Multiple Sclerosis: Diagnosis, Management, and Future OpportunitiesElisabetta Maida, Luigi Lavorgna
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 1, 2026
Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessmentFrancesco Brigo, Arian Zaboli, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2026
AI for clinical neurology: Comparing five large language models in neurological diagnosis and lesion localizationFrancesco Brigo, Arian Zaboli, Elisabetta Maida, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 24, 2023
Viral pericarditis following ocrelizumab in a multiple sclerosis patientGiuseppina Miele, Gianmarco Abbadessa, Elisabetta Maida, et al.
Journal of Neurology|August 16, 2025
First the B cells fall, then the T cells follow: temporal immunological shift with ocrelizumab in multiple sclerosisGianmarco Abbadessa, Elisabetta Maida, Simona Bonavita, et al.
Journal of Clinical Medicine|October 27, 2022
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case SeriesGianmarco Abbadessa, Elisabetta Maida, Giuseppina Miele, et al.
Multiple Sclerosis and Related Disorders|June 6, 2022
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic reviewGianmarco Abbadessa, Giuseppina Miele, Elisabetta Maida, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 19, 2023
Cost-Analysis of Telemedicine Interventions Compared with Traditional Care in the Management of Chronic Neurological Diseases: A Systematic ReviewElisabetta Maida, Vincenzo Bresciamorra, Maria Triassi, et al.
Journal of Clinical Medicine|April 13, 2024
A Review on the Feasibility and Efficacy of Home-Based Cognitive Remediation in People with Multiple SclerosisAngela Boschetti, Elisabetta Maida, Michelangelo Dini, et al.
Multiple Sclerosis and Related Disorders|November 25, 2023
Validation of the swallowing disturbance questionnaire in people with multiple sclerosisMaddalena Sparaco, Elisabetta Maida, Floriana Bile, et al.
Pageof 3